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Abstract
Bacterial and viral zoonotic infections comprise a practically endless, ever-expanding list of pathogens that have the potential to induce
human disease of varying severity, with varying means of transmission to humans (including vector-borne and foodborne agents) and of
varying epidemiology. Not all theoretically zoonotic pathogens are truly zoonotic in practice, the prime example being inﬂuenza viruses; avi-
ann H5N1 inﬂuenza remains strictly zoonotic, whereas novel H1N1 inﬂuenza displays an anthropocentric cycle that led to a pandemic,
despite being of zoonotic origin. The burden of disease induced by zoonotic and viral pathogens is enormous: there are more than ten bac-
terial zoonoses, each of which affects hundreds of thousands patients annually, often leading to chronic infections and causing signiﬁcant
economic losses of a medical and livestock-related nature. Viral zoonotic agents are constantly emerging or re-emerging, and are associated
with outbreaks of limited or expanded geographical spread: the typical trends of viral zoonotic infections, however, is to extend their eco-
logical horizon, sometimes in an unexpected but successful manner, as in the case of West Nile virus, and in other instances less effectively,
as was the case, fortunately, in the case of avian inﬂuenza. The majority of bacterial and viral zoonotic infections attract disproportionately
low scientiﬁc and public health interest. Understanding their burden may allow for improved surveillance and prevention measures.
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Introduction
Zoonotic infections are deﬁned as infections that can be
transmitted between vertebrate animals and humans, with
either human or the animal as the recipient, either through
direct contact, or as foodborne infections, or via intermediate
vectors such as ticks and mosquitoes [1]. Infections transmit-
ted from animals to humans are of concern regarding clinical
medicine, although diseases transmitted from humans to
animals may raise concern about species conservation, as in
the case of measles and inﬂuenza affecting primates (chimpan-
zees and mountain gorillas) through human contact [2].
Zoonoses affecting humans can originate in domestic ani-
mals or in wildlife; the latter are becoming an increasingly
important reservoir for human disease, as recognized in sus-
ceptible human groups, including hunters, adventurous tour-
ists camping in forests or cave explorers.
A detailed evaluation of all human pathogens a few years
ago demonstrated that the majority of infectious species
affecting humans are of a zoonotic nature [3]: of the 1415 spe-
cies recorded as pathogenic for humans in 2001, 868 (a stag-
gering 61%) could be characterized as zoonotic. Furthermore,
the zoonotic nature of a pathogen has been unanimously con-
sidered to be an independent factor that increases its potential
for emergence or re-emergence: Emergence refers to the
appearance of a newly recognized or newly evolved pathogen
or the appearance of a known pathogen in a geographical area
where it has never been recognized before. Re-emergence
similarly refers to known pathogens whose incidence in a given
geographical area (ranging from a county to the world in the
case of pandemics) is signiﬁcantly increasing or whose ecology
is newly altered, enhancing its potential to cause human dis-
ease (e.g. by using novel hosts, jumping from wild animals to
domestic ones, exhibiting a wider vector range, and so on) [4].
As the vast majority of novel species pathogenic for humans
recognized since 2001 are also of a zoonotic nature, including
SARS coronavirus and novel H1N1 inﬂuenza virus (pandemic
inﬂuenza of swine origin), one can presume that the spectrum
of human infection attributed to animals is continuing to evolve
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and remains understudied with regard to its actual burden:
The world of infectious diseases is currently dominated by
multidrug-resistant pathogens such as methicillin-resistant
Staphylococcus aureus, Pseudomonas aeruginosa (both technically
zoonotic pathogens), or Acinetobacter species and novel pan-
resistant strains: research and scientiﬁc publications are largely
targeted towards such pathogens. The world of humanitarian
relief and global public health campaigns is dominated by the
big three, AIDS, tuberculosis, and malaria. Although the ﬁrst is
strictly a zoonotic infection, jumping species to humans from
simians, and although the latter two are, at least in a minority
of cases, depending on the species implicated, also zoonotic, it
is not their zoonotic nature that has moved these infections to
the centre of the Millenium Development Goals, for example
[5]. Overshadowed by these scientiﬁc and public health tar-
gets, millions of people worldwide are susceptible to a wide
array of bacterial, viral, parasitic and fungal zoonotic infections
that cause millions of new annual cases, exhibit a considerate
mortality toll, are often followed by debilitating chronic seque-
lae, and are directly correlated with a signiﬁcant burden in
terms of veterinary medicine, agriculture, livestock produc-
tion, and regional and national economies. Zoonoses have
been disproportionately neglected until recently, remaining
the ‘other diseases’ of the Millenium Development Goals.
Interest in the impact of certain of these neglected diseases,
most of them zoonotic, has been slowly resurfacing [6] in
terms of science and research funding, but many other zoono-
ses remain the true neglected ‘neglected diseases’.
It is surprising that, apart from the 2001 effort by Taylor
et al. [3] cited above, there are scarce efforts to actually list
the existing zoonotic diseases and evaluate their global effect
in terms of actual disease and its socio-economic correla-
tions, particularly as almost all recent outbreaks, pandemic
threats, and the single 21st-century pandemic, have been of
zoonotic origin.
The present review focuses speciﬁcally on outlining in
detail the extensive range of zoonotic pathogens affecting
humans, and describing their burden in terms of morbidity
and mortality, and, where available information exists, the
impact of these pathogens on socio-economic parameters,
and their dynamics regarding emergence or re-emergence.
Bacterial Zoonoses
The clinically signiﬁcant bacterial zoonotic pathogens are
shown in Table 1, in alphabetical order. Numerous other
bacteria can be classiﬁed as zoonotic: the reader can refer to
the appendix of the review by Taylor et al. [3] for a listing of
other bacteria. Bacteria that cause a minimal clinical burden
of human disease, in terms of cases recorded or geographical
extent, have not been included. It should be noted that a
zoonotic potential exists for numerous other major patho-
gens, including Enterococcus sp. and P. aeruginosa, and also for
less frequent ones, such as Morganella morganii. However, the
vertebrate animal reservoirs of these pathogens, as well as
their animal-related life cycles, are of minimal signiﬁcance for
the burden and evolution of human disease, at least at pres-
ent; this is why such pathogens are not included in Table 1.
Viral Zoonoses
Table 2 shows viral zoonotic infections of clinical signiﬁcance
to humans: this is an ever-expanding list, in terms of both
pathogens included and importance, as recent years have
shown, with the emergence of novel pathogens of zoonotic
origin such as SARS coronavirus and novel H1N1 inﬂuenza
virus. However, the signiﬁcance of the diseases caused by both
of these viruses was related to their capacity for person-to-
person transmission, and not their zoonotic nature, in contrast
to, for example, the transmission of avian H5N1 inﬂuenza virus,
for which animal contact is necessary. Neither of these new
diseases would have emerged from the context of zoonotic
infection and species jumping from animals to humans. In a his-
torical context, the same could be said about human immuno-
deﬁciency virus. Person-to-person transmission is essential for
dengue outbreaks and sustaining dengue virus in nature, with
animals playing a minor role in this cycle; thus, dengue is not
considered to be an essential zoonosis. In order for Table 2 to
be more concise, viral pathogens that induce a minimal burden
of human disease (in terms of cases recorded or geographical
extent), e.g. eastern/western equine and St Louis encephalitis
(roughly ten annual cases in the USA each), are not included.
The same is true for viral pathogens that have been docu-
mented only occasionally in the past as pathogenic for humans.
As shown in Tables 1 and 2, a wide array of pathogens
are emerging or re-emerging, and more agents are being
introduced into non-endemic areas through the expansion of
international travel, in terms of both human travel and global
trade. As is also easily seen in Tables 1 and 2, millions of
annual cases of human disease are directly attributable to
bacterial and viral agents with direct zoonotic correlations.
The need for an interdisciplinary approach that extends
beyond medical and veterinary specialists cannot be stressed
strongly enough. Understanding the enormous economic
burden of these diseases might assist international and regio-
nal decision-makers in fully evaluating the huge effect of bac-
terial and viral zoonoses. The implementation of surveillance
and prevention measures for these zoonotic infections might
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TABLE 1. Clinically signiﬁcant bacterial zoonoses
Pathogen Comments
Anaplasma phagocytophilum Human granulocytic anaplasmosis has been increasing and expanding its incidence: recently recognized in Canada; an ongoing outbreak
is reported from China [7]. Exceeding 1000 cases annually in the USA, as of 2008 [8]
Bacillus anthracis The, fortunately, only case of emergence caused by deliberate release
Bartonella sp. There are 22 000 new annual cases of cat scratch disease reported annually in the USA [9]; Bartonellahenselae and Bartonella
clarridgeiae implicated. B. henselae, Bartonella elizabethae and Bartonella grahamii are causes of zoonotic endocarditis [10].
Bartonella vinsonii and Bartonella alsatica are also zoonotic. The spectrum of agents is likely to expand as novel species are recognized
Borrelia sp. Borrelia burgdorferi ecology has resulted in the re-emergence of Lyme disease in the USA: 28 921 conﬁrmed cases were reported in
2008 [8]. All other borreliae are zoonotic, excluding Borrelia recurrentis
Brucella sp. Brucella melitensis, Brucella abortus, Brucella canis, Brucella suis, Brucella pinnipedialis and Brucella ceti cause human disease. It is estimated
that there are more than 500 000 new cases annually [11], excluding chronic cases. Repeated outbreaks in former Communist
republics of Central Asia, and emergence in Balkan states, previously brucellosis-free. Experimental documentation of Brucella microti
zoonotic potential. Unknown zoonotic origin of novel non-characterized strains [12]
Burkholderia mallei and
Burkholderia pseudomallei
The former causes glanders, a typical but very rare zoonosis. Melioidosis annual incidence in northeast Thailand exceeds 12 cases/105
[13], with signiﬁcant mortality. Historical zoonotic outbreak in a Paris zoo in 1973 [14]
Campylobacter sp. Campylobacter jejuni is possibly the commonest zoonotic foodborne pathogen worldwide; almost 200 000 cases are recorded anually
in the European Union (EU) [15]. Campylobacter fetus, Campylobacter coli, Campylobacter hyointestinalis, Campylobacter lari and Campylo
bacter upsaliensis are also zoonotic
Capnocytophaga canimorsus and
Capnocytophaga cynodegmi
Dog-bite related; splenectomy and alcoholism may predispose—a recent review in The Netherlands detected more than ten annual
cases [16]
Chlamydophyla psittaci There are 10–20 cases of psittacosis documented annually by the CDC [8]. Micro-outbreaks are irregularly reported, predominantly
from Australia, but also in Japan and The Netherlands
Clostridium sp. Can be considered to be zoonotic foodborne diseases, although the zoonotic aspect is of limited signiﬁcance [17].
Clostridium botulinum infection is not typically zoonotic, even when foodborne
Corynebacterium ulcerans Corynebacterium ulcerans is increasingly recognized as an important factor in possible diphtheria re-emergence [18]. Other
non-diphtheria species are of limited signiﬁcance
Coxiella burnetii Massively under-reported worldwide, despite being acknowledged as an important cause of endocarditis. There were 106 acute cases
in the USA in 2008 [8]. A recent Netherlands outbreak highlighted limited surveillance issues [19], and increased the number of
reported cases in the EU in 2008 to 1594. Germany, Spain, Slovenia and the UK report most other cases [15]
Ehrlichia chaffeensis and
Ehrlichia ewingi
The number of human monocytotropic ehrlichiosis cases reported in the USA is continuously increasing, exceeding 900 in 2008 [8].
Human ewingii ehrlichiosis is more rare
Escherichia coli The O157:H7 strain is consistently causing zoonotic foodborne and waterborne outbreaks [20]. Secondary effect through risk of
haemolytic–uraemic syndrome development
Francisella tularensis The tularaemia outbreak in Kosovo underlined the relationship of zoonoses with socio-economic and political factors [21]. Outbreaks
of varying intensity have also been reported in Bulgaria, Georgia, and Turkey. Disease is rare (or understudied) in the EU;
approximately 100 cases are recorded annually in the USA [8]
Helicobacter sp. A speculative zoonotic potential for non-Helicobacter pylori Helicobacter sp. exists [22], although the role of animals in transmission of
these species to humans has not been proven adequately
Leptospira sp. The annual burden of leptospirosis is largely underestimated (inadequate surveillance; majority of cases mild or subclinical) [23]. The
annual number of cases may exceed 500 000, the majority arising from India and Southeast Asia
Listeria sp. Increasingly recognized in Europe—1300–1500 EU cases annually [15]; declining incidence in the USA that has stabilized below
0.3 cases/105 [8]. A recent Canadian outbreak exhibited signiﬁcant mortality [24]
Mycobacterium sp. Mycobacterium bovis still causes a small percentage of human tuberculosis by transmission from cattle or possums, as also observed
less often with Mycobacterium caprae. Also included are Mycobacterium marinum, Mycobacterium microti, Mycobacterium avium,
Mycobacteriumgenavense, possibly Mycobacterium malmoense, and Mycobacteriumfarcinogenes. There has been a long debate on the
potential aetiological relationship between M. avium paratuberculosis and Crohn’s disease in humans [25]. The mycobacterial life cycle
leading to Mycobacterium ulcerans human infection and Buruli ulcer, and the signiﬁcance of animal reservoirs in this cycle, have not
yet been clariﬁed adequately enough for it to be classiﬁed as zoonotic or non-zoonotic
Orientia tsutsugamushi The burden of annual scrub typhus cases in Southeast Asia and the Southwest Paciﬁc approaches 1 000 000 [26]
Pasteurella sp. Pasteurellosis remains a relatively rare human infection,; it has been better understood and studied in animal disease
Rickettsia sp. The numbers of cases of Rocky Mountain spotted fever reported annually were increasing in the USA in the early 2000s, exceeding
1000 cases in 2002. For rickettsial pox, the mild nature of human disease may contribute to underdiagnosis and under-reporting.
The same is partly true for Mediterranean spotted fever, which can, however, be considered to be endemic in the region [27], and
for African tick bite fever [26]. The endemicity of North Asian tick typhus remains understudied, whereas Queensland tick typhus
and Japanese spotted fever can be considered to be both rare and localized. Murine typhus is generally sporadic and under-reported.
Epidemic typhus shows an expanding animal reservoir frame (including ﬂying squirrels in the USA), exhibits the secondary effect of
BrillZinsser disease, and, more importantly, exhibits signiﬁcant outbreak dynamics, which are nowhere better evaluated than in the
notorious Burundi outbreak [28]
Salmonella sp. Excluding Salmonella typhi, 51 030 cases of salmonellosis were recorded by the CDC in 2008 [8], the majority of which were caused
by Salmonella enteritidis and Salmonella typhimurium; S. enteritidis was responsible for the 2008 US outbreak, with more than 1000
cases, more than 250 hospitalizations, and at least one fatality. More than 100 000 cases are recorded in the EU annually [15]
Shigella sp. Shigellosis remains a major health issue worldwide, with tens of millions of cases and tens of thousands of deaths annually being
attributed to it, particularly in young children, according to the WHO. Twenty-two thousand six hundred and twenty-ﬁve cases of
shigellosis were reported by the CDC in 2008 [8]. EU data are inadequate on the subject
Staphylococcus aureus The zoonotic signiﬁcance of S. aureus is predominantly related to the role that animal reservoirs (such as pigs) play in expanding and
sustaining the presence of methicillin-resistant S. aureus in the community, as demonstrated in The Netherlands [29]
Streptococcus sp. Streptococcus suis is increasingly recognized in East Asia—a Chinese outbreak in 2004 resulted in 38/204 fatalities [30].
An Streptococcus equi outbreak associated with goat cheese occurred in Finland in 2003 [31]. The frequency of Streptococcuscanis
infection may be underestimated. Streptococcus acidominimus is also zoonotic. The zoonotic signiﬁcance of Streptococcus bovis
is of minor importance concerning its primary manifestations in human disease
Vibrio sp. Including Vibrio parahaemolyticus and Vibrio vulniﬁcus, characteristically identiﬁed in the USA in the aftermath of Hurricane Katrina [32],
but excluding Vibrio cholerae. Also with zoonotic potential are Vibrio alginolyticus, Vibrio ﬂuvialis, Vibrio furnissii, Grimontia hollisae,
and Vibrio mimicus [33]
Yersinia sp. Plague remains, for both historical and purely scientiﬁc reasons, a major bacterial threat [34]; the WHO data for 2003 recorded
more than 2000 cases, with mortality reaching 8.5%; the vast majority of cases were in Africa. Isolated cases are reported annually
in the USA. Yersiniosis annual incidence has been declining in the EU—8346 cases were recorded in 2008, the vast majority of them
caused by Yersinia enterocolitica
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also allow for enhanced preparedness regarding the emer-
gence or re-emergence of similar pathogens with the poten-
tial to cause epidemics or pandemics.
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